2025年全球心血管和軟組織修復貼片市場報告

近年來，心血管和軟組織修復補片市場規模迅速擴張，從2024年的43.9億美元成長到2025年的48.5億美元，複合年成長率為10.5%。預測期內的成長可歸因於人口老化、慢性病增加、意識提升和早期發現、醫療基礎設施建設以及疝氣修復需求旺盛。

心血管和軟組織修復貼片市場規模預計將在未來幾年快速成長，到2029年將達到73.6億美元，年複合成長率（CAGR）為11.0%。預測期內的成長可歸因於微創手術的興起、診斷工具的改進、個人化醫療需求的不斷成長以及研發的加強。預測期內的主要趨勢包括技術創新、外科手術技術的進步、再生醫學的進步、3D列印以及數據分析和人工智慧(AI)的應用。

心血管和軟組織修復補片是由試管內培養組織和聚合物組成的實驗室人工組織。這些補片旨在修復受損的身體組織，為受損的心肌提供機械再生支持，並恢復受損組織的功能特性，以治療心血管疾病。

用於製造心血管和軟組織修復補片的主要原料包括發泡聚四氟乙烯 (ePTFE)、生物材料、組織工程材料和其他相關原料。 ePTFE 是一種常用於導管和心臟縫線等醫療器材的材料，由四氟乙烯聚合物單元組成，以其生物相容性而聞名。因此，其產品包括合成補片和生物相容性補片，其應用範圍從心臟修復到各種心臟相關疾病，包括心房中隔缺損、心室中隔缺損和血管修復。心血管和軟組織修復補片的最終使用者包括醫院、門診手術中心和專科診所。

2025年春季，美國關稅上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司（The Business Research Company）新報告系列的一部分，該系列提供心血管和軟組織修復貼片市場統計數據，包括全球市場規模、各地區市場佔有率、競爭對手的市場佔有率、詳細的心血管和軟組織修復貼片細分市場、市場趨勢和機遇，以及您在心血管和軟組織修復貼片行業取得成功所需的數據。這份心血管和軟組織修復貼片市場研究報告對該行業的現狀和未來走勢進行了詳細分析，為您提供所需的一切資訊的完整觀點。

未來五年預測成長率為11.0%，較我們先前對該市場的預測略有下降0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。這可能會透過對來自巴西和瑞士等主要地區的牛心包組織和聚四氟乙烯 (PTFE) 增強網徵收關稅直接影響美國，並可能導致血管重組成本上升，並可能導致緊急心臟修復物資短缺。由於互惠關稅以及貿易緊張局勢和限制措施升級對全球經濟和貿易的負面影響，這種影響也將更加廣泛地顯現。

預計對心臟病相關貼片不斷成長的需求將推動心血管和軟組織修復貼片市場的成長。心臟疾病包括與心臟和血管相關的各種疾病。對治療心臟疾病的貼片不斷成長的需求在很大程度上受到吸煙和飲酒等生活方式因素的影響。例如，2024 年 5 月，總部位於喬治亞的國家公共衛生組織疾病管制與預防中心 (CDC) 報告稱，心臟病將導致 2022 年 702,880 人死亡，佔死亡人數的五分之一。這相當於每 33 秒就有一人死於心血管疾病。在美國，每年約有 805,000 人心臟病發作，其中 605,000 人是首次心臟病發作，20 萬人曾經心臟病發作。因此，預計對心臟病相關貼片不斷成長的需求將在未來幾年推動心血管和軟組織修復貼片市場的發展。

預計政府在醫療保健研究和開發方面的舉措將進一步推動心血管和軟組織修復貼片市場的成長。政府當局積極參與實施計劃、政策和計劃，以應對醫療保健挑戰、實現具體目標並促進社會積極變化。 2022 年，英國政府透過衛生和社會保障部宣布投資 2.6 億英鎊（2.7065 億美國）加強醫療保健研究和製造。這項承諾旨在透過引入隱私保護平台和臨床研究服務來支持 NHS主導的健康研究。此外，還撥款 6,000 萬英鎊（6,360 萬美國）用於促進英國生命科學製造業的擴張。因此，政府在醫療保健研究和開發方面的舉措在推動心血管和軟組織修復貼片市場方面發揮關鍵作用。

心血管和軟組織修復貼片市場的一個主要趨勢是技術進步的融合。該領域的公司正在積極開發創新產品和技術，以滿足日益成長的市場需求。 2022年10月，印度醫療科技公司Dozee推出了一款基於人工智慧的心電圖貼片，用於遠端心臟監測。這款心電圖貼片設計緊湊、靈活、輕便，為醫生接收遠端警報和存取患者即時、連續的心電圖數據提供了便捷的解決方案。這些技術進步的整合正在促進整個心血管和軟組織修復貼片市場的成長和重要性。

心血管和軟組織修復貼片市場的主要企業正在積極開發一次性心臟貼片等創新產品，推動市場收益。一次性心臟貼片是一種黏性醫療設備，設計用於直接貼在心臟上，提供機械支撐並減少心肌拉伸。 2022 年 10 月，美國著名醫療設備公司 Mawi 推出了 Mawi 心臟貼片，這是一款一次性雙導極心臟監視器，可即時追蹤心臟健康狀況。這款創新貼片可在診所或家中靈活使用，患者可配戴長達七天。 Mawi 心臟貼片代表了心臟監護技術的重大進步，有可能改善患者的預後並挽救生命。

2024年6月，美國醫療設備製造商史賽克（Stryker）收購了Artelon，收購金額未揭露。此次收購旨在擴大公司在關節保護和軟組織重組的產品系列。 Artelon專注於開發用於軟組織加固和修復的創新生醫材料，尤其在運動醫學和肢體手術領域。 Artelon總部位於喬治亞，專注於醫療設備製造。

心血管和軟組織修復貼片市場的主要企業包括 B Braun、Baxter International Inc.、CorMatrix Cardiovascular Inc.、Cryolife Inc.、Edwards Lifesciences Corporation、LeMaitre Vascular Inc.、Anteris Technologies Limited、Abbott Laboratories、Terumo Medical Corporation、Integra Life Corporation、Anteris Technologies Limited、Abbott Laboratories、Terumo Medical Corporation、Integra Life Corporation、Sciences Inc.L.S. Corporation、Medtronic Inc、ACell Inc.、Tissue Regenix Group Plc、Aroa Biosurgery Ltd.、Zimmer Biomet、LifeNet Health Inc.、Becton Dickinson and Company、Boston Scientific Corporation、Cook Medical、Endologix Inc.、Getinge AB、Vascular Solutions Inc.、AngioDynamics Inc.、Sampillan. Surgical Inc.、Admedus Ltd.、LabCor Corp.、Smith &Nephew plc 和 Organogenesis Inc.

2024年，北美是心血管和軟組織修復貼片市場最大的地區。預計亞太地區將成為預測期內成長最快的地區。心血管和軟組織修復貼片市場報告涵蓋的地區包括亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

心血管和軟組織修復貼片市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國和美國。

心血管和軟組織修復補片市場包括異種移植補片和同種異體移植補片的銷售。該市場的價值是指“出廠價”，即商品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的價值。該市場中的商品價值還包括商品製造商提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球心血管和軟組織修復貼片：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 最終用途產業分析
• 全球心血管和軟組織修復貼片市場：成長率分析
• 全球心血管與軟組織修復貼片市場表現：規模與成長，2019-2024
• 全球心血管與軟組織修復貼片市場預測：規模與成長，2024-2029年，2034年
• 全球心血管和軟組織修復補片：總目標市場（TAM）

第6章 市場細分

• 全球心血管和軟組織修復貼片市場（按材料、性能和預測），2019-2024 年、2024-2029 年、2034 年
• ePTFE
• 生物材料與組織工程材料
• 其他成分
• 全球心血管和軟組織修復貼片市場：按產品、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 合成補片
• 生物補丁
• 全球心血管和軟組織修復貼片市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 心臟修復
• 心房中膈缺損症
• 共享中庭
• 心內膜墊缺損
• 室間隔缺損
• 法洛氏四合症
• 右心室流出道重組
• 縫合出血
• 血管修復與重組
• 大血管轉位
• 全球心血管和軟組織修復貼片市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
• 醫院
• 門診手術中心
• 專科診所
• 全球心血管和軟組織修復貼片市場：按膨體聚四氟乙烯 (ePTFE) 細分，類型，實際及預測，2019-2024 年、2024-2029 年、2034 年
• 不可吸收ePTFE貼片
• 可吸收ePTFE貼片
• 全球心血管和軟組織修復貼片市場：按生物材料和組織工程材料細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 膠原蛋白蛋白貼片
• 合成聚合物貼片（例如聚丙烯、聚氨酯）
• 去細胞組織補片
• 全球心血管及軟組織修復貼片市場：依其他原料細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
• 矽酮
• 水凝膠基材料
• 天然材質

第7章 區域和國家分析

• 全球心血管和軟組織修復貼片市場：區域分析、預測和成長，2019-2024 年、2024-2029 年、2034 年
• 全球心血管及軟組織修復貼片市場：國家、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

• 心血管和軟組織修復貼片市場：競爭格局
• 心血管和軟組織修復貼片市場：公司簡介
  • B Braun Overview, Products and Services, Strategy and Financial Analysis
  • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • CorMatrix Cardiovascular Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Cryolife Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

• LeMaitre Vascular Inc.
• Anteris Technologies Limited
• Abbott Laboratories
• Terumo Medical Corporation
• Integra LifeSciences Corporation
• WL Gore & Associates Inc.
• Arthrex Inc.
• Johnson & Johnson
• Stryker Corporation
• LifeCell Corporation
• Medtronic Inc.
• ACell Inc.
• Tissue Regenix Group Plc
• Aroa Biosurgery Ltd.
• Zimmer Biomet

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

• 2029年心血管和軟組織修復貼片市場：提供新機會的國家
• 2029年心血管與軟組織修復貼片市場：細分市場帶來新機會
• 2029年心血管和軟組織修復貼片市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第36章 附錄

Cardiovascular and soft tissue repair patches are artificial tissues created in the laboratory, composed of tissues grown in vitro and polymers. These patches serve the purpose of restoring damaged body tissues, providing mechanical regeneration support for injured myocardium layers, and reinstating the functional characteristics of damaged tissues for the treatment of cardiovascular diseases.

The primary raw materials used in the production of cardiovascular and soft tissue repair patches include ePTFE (expanded Polytetrafluoroethylene), biomaterial and tissue-engineered material, and other relevant raw materials. ePTFE, a material commonly used in medical devices like catheters and cardiac sutures, is composed of tetrafluoroethylene polymer units and is known for its biocompatible properties. The resulting products include synthetic patches and biological patches, with applications ranging from cardiac repair to various heart-related conditions such as atrial septal defect, ventricular septal defect, and vascular repair. The end users of cardiovascular and soft tissue repair patches encompass hospitals, ambulatory surgical centers, and specialty clinics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The cardiovascular and soft tissue repair patches market research report is one of a series of new reports from The Business Research Company that provides cardiovascular and soft tissue repair patches market statistics, including cardiovascular and soft tissue repair patches industry global market size, regional shares, competitors with a cardiovascular and soft tissue repair patches market share, detailed cardiovascular and soft tissue repair patches market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular and soft tissue repair patches industry. This cardiovascular and soft tissue repair patches market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiovascular and soft tissue repair patches market size has grown rapidly in recent years. It will grow from $4.39 billion in 2024 to $4.85 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to aging population, rise in chronic diseases, awareness and early detection, healthcare infrastructure growth, and high demand for hernia repairs.

The cardiovascular and soft tissue repair patches market size is expected to see rapid growth in the next few years. It will grow to $7.36 billion in 2029 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to minimally invasive procedures, enhanced diagnostic tools, increasing demand for personalized medicine, and increasing research and development. Major trends in the forecast period include technological innovations, advancements in surgical techniques, advancements in regenerative medicine, 3D printing, the use of data analytics and artificial intelligence (ai).

The forecast of 11.0% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on bovine pericardium tissue and polytetrafluoroethylene (PTFE) reinforcement meshes, sourced from key regions such as Brazil and Switzerland, which could lead to higher costs for vascular reconstructions and potential shortages in emergency cardiac repairs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing demand for patches related to cardiac disease is projected to drive the growth of the cardiovascular and soft tissue repair patches market. Cardiac disease encompasses a range of disorders associated with the heart and blood vessels. The rising need for patches addressing cardiac conditions is largely influenced by lifestyle factors, including smoking and alcohol consumption. For instance, in May 2024, the Centers for Disease Control and Prevention (CDC), a national public health agency based in Georgia, reported that in 2022, heart disease led to 702,880 deaths, accounting for 1 in every 5 fatalities. This equates to one individual succumbing to cardiovascular disease every 33 seconds. Each year, about 805,000 people in the United States suffer a heart attack, of which 605,000 are experiencing their first heart attack, while 200,000 have had a previous heart attack. Thus, the increasing demand for patches related to cardiac disease is expected to drive the cardiovascular and soft tissue repair patches market in the coming years.

Anticipated growth in the cardiovascular and soft tissue repair patches market is further propelled by government initiatives focused on research and development in healthcare. Government authorities are actively involved in implementing programs, policies, and projects to address healthcare challenges, achieve specific goals, and foster positive societal changes. In 2022, the UK government, through the Department of Health and Social Care, announced a substantial investment of £260 million (US $270.65 million) to boost healthcare research and manufacturing. This commitment aims to support NHS-led health research by introducing privacy-preserving platforms and clinical research services. Additionally, £60 million (US $63.60 million) has been allocated to facilitate the expansion of life sciences manufacturing in the UK. Thus, government initiatives in healthcare research and development play a pivotal role in propelling the cardiovascular and soft tissue repair patches market.

A significant trend gaining traction in the cardiovascular and soft tissue repair patches market is the integration of technological advancements. Companies operating in this sector are actively engaged in developing innovative products and technologies to meet growing market demands. In October 2022, Dozee, an India-based healthcare technology company, introduced an AI-based ECG patch designed for remote cardiac monitoring. This ECG patch, characterized by its small, flexible, and lightweight design, provides a convenient solution for physicians to remotely receive alerts and access live and continuous ECG data from patients. The incorporation of such technological advancements contributes to the overall growth and relevance of the cardiovascular and soft tissue repair patches market.

Leading companies in the cardiovascular and soft tissue repair patches market are actively engaged in developing innovative products, including single-use heart patches, to drive market revenues. The single-use heart patch is an adhesive medical device designed to be directly applied to the heart, providing mechanical support and reducing the stretching of the heart muscle. In October 2022, Mawi, a prominent US-based medical device company, introduced the Mawi Heart Patch-a single-use, two-lead cardiac monitor capable of real-time heart health tracking. This innovative patch offers flexibility in application, allowing for in-clinic or at-home use, and can be worn by patients for up to seven days. The Mawi Heart Patch represents a significant advancement in cardiac monitoring technology, with the potential to enhance patient outcomes and contribute to saving lives.

In June 2024, Stryker, a US-based manufacturer of medical equipment, acquired Artelon for an undisclosed sum. This acquisition is intended to expand its product portfolio in joint preservation and soft tissue reconstruction. Artelon focuses on developing innovative biomaterials for soft tissue reinforcement and repair, especially in the areas of sports medicine and extremities procedures. Artelon is based in Georgia and specializes in medical equipment manufacturing.

Major companies operating in the cardiovascular and soft tissue repair patches market include B Braun, Baxter International Inc., CorMatrix Cardiovascular Inc., Cryolife Inc., Edwards Lifesciences Corporation, LeMaitre Vascular Inc., Anteris Technologies Limited, Abbott Laboratories, Terumo Medical Corporation, Integra LifeSciences Corporation, W. L. Gore & Associates Inc., Arthrex Inc., Johnson & Johnson, Stryker Corporation, LifeCell Corporation, Medtronic Inc., ACell Inc., Tissue Regenix Group Plc, Aroa Biosurgery Ltd., Zimmer Biomet, LifeNet Health Inc., Becton Dickinson and Company, Boston Scientific Corporation, Cook Medical, Endologix Inc., Getinge AB, Vascular Solutions Inc., AngioDynamics Inc., Merit Medical Systems Inc., Penumbra Inc., Glycar SA Pty Ltd., Biointegral Surgical Inc., Admedus Ltd., LabCor Corp., Smith & Nephew plc, Organogenesis Inc.

North America was the largest region in the cardiovascular and soft tissue repair patches market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiovascular and soft tissue repair patches market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the cardiovascular and soft tissue repair patches market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The cardiovascular and soft tissue repair patches market consists of sales of xenogeneic patch and allogeneic patch. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiovascular And Soft Tissue Repair Patches Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiovascular and soft tissue repair patches market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiovascular and soft tissue repair patches ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiovascular and soft tissue repair patches market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Raw Materials: ePTFE; Biomaterial And Tissue-Engineered Material; Other Raw Materials
• 2) By Product: Synthetic Patch; Biologic Patch
• 3) By Application: Cardiac Repair; Atrial Septal Defect; Common Atrium; Defects Of The Endocardial Cushion; Ventricular Septal Defect; Tetralogy Of Fallot; Right Ventricular Outflow Tract Reconstruction; Suture Bleeding; Vascular Repair And Reconstruction; Transposition Of The Great Vessels
• 4) By End User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics
• Subsegments:
• 1) By ePTFE (Expanded Polytetrafluoroethylene): Non-Absorbable ePTFE Patches; Absorbable ePTFE Patches
• 2) By Biomaterial and Tissue-Engineered Material: Collagen-Based Patches; Synthetic Polymer-Based Patches (e.g., Polypropylene, Polyurethane); Decellularized Tissue Patches
• 3) By Other Raw Materials: Silicones; Hydrogel-Based Materials; Natural Materials
• Companies Mentioned: B Braun; Baxter International Inc.; CorMatrix Cardiovascular Inc.; Cryolife Inc.; Edwards Lifesciences Corporation; LeMaitre Vascular Inc.; Anteris Technologies Limited; Abbott Laboratories; Terumo Medical Corporation; Integra LifeSciences Corporation; W. L. Gore & Associates Inc.; Arthrex Inc.; Johnson & Johnson; Stryker Corporation; LifeCell Corporation; Medtronic Inc.; ACell Inc.; Tissue Regenix Group Plc; Aroa Biosurgery Ltd.; Zimmer Biomet; LifeNet Health Inc.; Becton Dickinson and Company; Boston Scientific Corporation; Cook Medical; Endologix Inc.; Getinge AB; Vascular Solutions Inc.; AngioDynamics Inc.; Merit Medical Systems Inc.; Penumbra Inc.; Glycar SA Pty Ltd.; Biointegral Surgical Inc.; Admedus Ltd.; LabCor Corp.; Smith & Nephew plc; Organogenesis Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiovascular And Soft Tissue Repair Patches Market Characteristics

3. Cardiovascular And Soft Tissue Repair Patches Market Trends And Strategies

4. Cardiovascular And Soft Tissue Repair Patches Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cardiovascular And Soft Tissue Repair Patches Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cardiovascular And Soft Tissue Repair Patches PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cardiovascular And Soft Tissue Repair Patches Market Growth Rate Analysis
• 5.4. Global Cardiovascular And Soft Tissue Repair Patches Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cardiovascular And Soft Tissue Repair Patches Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cardiovascular And Soft Tissue Repair Patches Total Addressable Market (TAM)

6. Cardiovascular And Soft Tissue Repair Patches Market Segmentation

• 6.1. Global Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• ePTFE
• Biomaterial And Tissue-Engineered Material
• Other Raw Materials
• 6.2. Global Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Synthetic Patch
• Biologic Patch
• 6.3. Global Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiac Repair
• Atrial Septal Defect
• Common Atrium
• Defects Of The Endocardial Cushion
• Ventricular Septal Defect
• Tetralogy Of Fallot
• Right Ventricular Outflow Tract Reconstruction
• Suture Bleeding
• Vascular Repair And Reconstruction
• Transposition Of The Great Vessels
• 6.4. Global Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• 6.5. Global Cardiovascular And Soft Tissue Repair Patches Market, Sub-Segmentation Of ePTFE (Expanded Polytetrafluoroethylene), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Absorbable ePTFE Patches
• Absorbable ePTFE Patches
• 6.6. Global Cardiovascular And Soft Tissue Repair Patches Market, Sub-Segmentation Of By Biomaterial and Tissue-Engineered Material, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Collagen-Based Patches
• Synthetic Polymer-Based Patches (e.g., Polypropylene, Polyurethane)
• Decellularized Tissue Patches
• 6.7. Global Cardiovascular And Soft Tissue Repair Patches Market, Sub-Segmentation Of Other Raw Materials, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Silicones
• Hydrogel-Based Materials
• Natural Materials

7. Cardiovascular And Soft Tissue Repair Patches Market Regional And Country Analysis

• 7.1. Global Cardiovascular And Soft Tissue Repair Patches Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cardiovascular And Soft Tissue Repair Patches Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cardiovascular And Soft Tissue Repair Patches Market

• 8.1. Asia-Pacific Cardiovascular And Soft Tissue Repair Patches Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cardiovascular And Soft Tissue Repair Patches Market

• 9.1. China Cardiovascular And Soft Tissue Repair Patches Market Overview
• 9.2. China Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cardiovascular And Soft Tissue Repair Patches Market

• 10.1. India Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cardiovascular And Soft Tissue Repair Patches Market

• 11.1. Japan Cardiovascular And Soft Tissue Repair Patches Market Overview
• 11.2. Japan Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cardiovascular And Soft Tissue Repair Patches Market

• 12.1. Australia Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cardiovascular And Soft Tissue Repair Patches Market

• 13.1. Indonesia Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cardiovascular And Soft Tissue Repair Patches Market

• 14.1. South Korea Cardiovascular And Soft Tissue Repair Patches Market Overview
• 14.2. South Korea Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cardiovascular And Soft Tissue Repair Patches Market

• 15.1. Western Europe Cardiovascular And Soft Tissue Repair Patches Market Overview
• 15.2. Western Europe Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cardiovascular And Soft Tissue Repair Patches Market

• 16.1. UK Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cardiovascular And Soft Tissue Repair Patches Market

• 17.1. Germany Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cardiovascular And Soft Tissue Repair Patches Market

• 18.1. France Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cardiovascular And Soft Tissue Repair Patches Market

• 19.1. Italy Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cardiovascular And Soft Tissue Repair Patches Market

• 20.1. Spain Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cardiovascular And Soft Tissue Repair Patches Market

• 21.1. Eastern Europe Cardiovascular And Soft Tissue Repair Patches Market Overview
• 21.2. Eastern Europe Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cardiovascular And Soft Tissue Repair Patches Market

• 22.1. Russia Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cardiovascular And Soft Tissue Repair Patches Market

• 23.1. North America Cardiovascular And Soft Tissue Repair Patches Market Overview
• 23.2. North America Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cardiovascular And Soft Tissue Repair Patches Market

• 24.1. USA Cardiovascular And Soft Tissue Repair Patches Market Overview
• 24.2. USA Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cardiovascular And Soft Tissue Repair Patches Market

• 25.1. Canada Cardiovascular And Soft Tissue Repair Patches Market Overview
• 25.2. Canada Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cardiovascular And Soft Tissue Repair Patches Market

• 26.1. South America Cardiovascular And Soft Tissue Repair Patches Market Overview
• 26.2. South America Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cardiovascular And Soft Tissue Repair Patches Market

• 27.1. Brazil Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cardiovascular And Soft Tissue Repair Patches Market

• 28.1. Middle East Cardiovascular And Soft Tissue Repair Patches Market Overview
• 28.2. Middle East Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cardiovascular And Soft Tissue Repair Patches Market

• 29.1. Africa Cardiovascular And Soft Tissue Repair Patches Market Overview
• 29.2. Africa Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cardiovascular And Soft Tissue Repair Patches Market Competitive Landscape And Company Profiles

• 30.1. Cardiovascular And Soft Tissue Repair Patches Market Competitive Landscape
• 30.2. Cardiovascular And Soft Tissue Repair Patches Market Company Profiles
  • 30.2.1. B Braun Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. CorMatrix Cardiovascular Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Cryolife Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Cardiovascular And Soft Tissue Repair Patches Market Other Major And Innovative Companies

• 31.1. LeMaitre Vascular Inc.
• 31.2. Anteris Technologies Limited
• 31.3. Abbott Laboratories
• 31.4. Terumo Medical Corporation
• 31.5. Integra LifeSciences Corporation
• 31.6. W. L. Gore & Associates Inc.
• 31.7. Arthrex Inc.
• 31.8. Johnson & Johnson
• 31.9. Stryker Corporation
• 31.10. LifeCell Corporation
• 31.11. Medtronic Inc.
• 31.12. ACell Inc.
• 31.13. Tissue Regenix Group Plc
• 31.14. Aroa Biosurgery Ltd.
• 31.15. Zimmer Biomet

32. Global Cardiovascular And Soft Tissue Repair Patches Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiovascular And Soft Tissue Repair Patches Market

34. Recent Developments In The Cardiovascular And Soft Tissue Repair Patches Market

35. Cardiovascular And Soft Tissue Repair Patches Market High Potential Countries, Segments and Strategies

• 35.1 Cardiovascular And Soft Tissue Repair Patches Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cardiovascular And Soft Tissue Repair Patches Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cardiovascular And Soft Tissue Repair Patches Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer